Delivery Order SPE2DB24D9223-SPE2DB25FKDZW

Award Date 1/2/25
Potential Completion Date 1/24/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $36,558.00 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Privigen 10% vial (200 mL) and has a completion date of February 8, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $16,467.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Privigen 10% solution, a specialized biologic medication. This delivery order contract is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $53,238.60 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The delivery order is for the supply of 200 ml vials of the pharmaceutical product Privigen 10%. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which enables the DLA to issue...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $32,934.00 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of Privigen 10% vial, a branded pharmaceutical product. This delivery order is issued under DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which allows the agency to place orders for a wide range of branded and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $12,801.60 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the pharmaceutical product Privigen 10% Vial 200ML and has a completion date of July 29, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical supplies to support the recurring needs of military health...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $40,005.00 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of Privigen 10% vial, a 200 ml immunoglobulin product, with a period of performance through May 22, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. under the DLA's SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $31,074.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Privigen 10% solution in 200 ml vials. This award is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group Inc. for medical supply support to the Department of Defense, valued at up to $499,999,999 and running through December 31,...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $32,004.00 contract is for the delivery of Privigen 10% vials, a pharmaceutical product, with a completion date of March 1, 2024. This delivery order is part of a larger indefinite delivery contract (SPE2DB) that DMS Pharmaceutical Group holds with the Defense Logistics Agency, valued at up...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $24,003.00, is for the delivery of Privigen 10% vial (100ml) to support the recurring medical supply needs of military health facilities. This contract is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc., valued at up to...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $41,101.20, is for the delivery of Privigen 10% vial 400 ml, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC...
  • SPE2DB24D9223
    Indefinite Delivery Contract
  • SPE2DB24D9223-SPE2DB25FKDZW
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $15,412.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Privigen 10% vial 200ml, a specialized medical product, with a completion date of January 24, 2025. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This latest award is not associated with any set-aside designations.

Generated 4/6/25, 12:48 AM